260 related articles for article (PubMed ID: 22123684)
1. Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.
Domínguez-Herrera J; Docobo-Pérez F; López-Rojas R; Pichardo C; Ruiz-Valderas R; Lepe JA; Pachón J
Antimicrob Agents Chemother; 2012 Feb; 56(2):613-7. PubMed ID: 22123684
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
Domínguez-Herrera J; López-Rojas R; Smani Y; Labrador-Herrera G; Pachón J
Int J Antimicrob Agents; 2016 Dec; 48(6):661-665. PubMed ID: 28128094
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.
García-de-la-Mària C; Marco F; Armero Y; Soy D; Moreno A; del Río A; Almela M; Cervera C; Ninot S; Falces C; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
Antimicrob Agents Chemother; 2010 Jul; 54(7):2781-6. PubMed ID: 20421394
[TBL] [Abstract][Full Text] [Related]
4. [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].
Öcal DN; Dolapçı İ; Gençtürk Z; Tekeli A
Mikrobiyol Bul; 2017 Jul; 51(3):220-235. PubMed ID: 28929959
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections.
Van Praagh AD; Li T; Zhang S; Arya A; Chen L; Zhang XX; Bertolami S; Mortin LI
Antimicrob Agents Chemother; 2011 Sep; 55(9):4081-9. PubMed ID: 21709082
[TBL] [Abstract][Full Text] [Related]
7. Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128.
Poonacha N; Nair S; Desai S; Tuppad D; Hiremath D; Mohan T; Vipra A; Sharma U
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559263
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.
Saleh-Mghir A; Muller-Serieys C; Dinh A; Massias L; Crémieux AC
Antimicrob Agents Chemother; 2011 Oct; 55(10):4589-93. PubMed ID: 21825285
[TBL] [Abstract][Full Text] [Related]
9. Effect of daptomycin and vancomycin on Staphylococcus epidermidis biofilms: An in vitro assessment using fluorescence in situ hybridization.
Sutrave S; Kikhney J; Schmidt J; Petrich A; Wiessner A; Kursawe L; Gebhardt M; Kertzscher U; Gabel G; Goubergrits L; Affeld K; Moter A
PLoS One; 2019; 14(8):e0221786. PubMed ID: 31454398
[TBL] [Abstract][Full Text] [Related]
10. Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis.
Park KH; Greenwood-Quaintance KE; Schuetz AN; Mandrekar JN; Patel R
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855069
[TBL] [Abstract][Full Text] [Related]
11. Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report.
Duah M
Ann Clin Microbiol Antimicrob; 2010 Feb; 9():9. PubMed ID: 20167084
[TBL] [Abstract][Full Text] [Related]
12. Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant.
Albac S; Labrousse D; Hayez D; Anzala N; Bonnot D; Chavanet P; Aslangul E; Croisier D
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740562
[TBL] [Abstract][Full Text] [Related]
13. Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm.
Olson ME; Slater SR; Rupp ME; Fey PD
J Antimicrob Chemother; 2010 Oct; 65(10):2164-71. PubMed ID: 20719763
[TBL] [Abstract][Full Text] [Related]
14. Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.
Presterl E; Hajdu S; Lassnigg AM; Hirschl AM; Holinka J; Graninger W
Antimicrob Agents Chemother; 2009 Aug; 53(8):3205-10. PubMed ID: 19451280
[TBL] [Abstract][Full Text] [Related]
15. Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Marco F; de la Mària CG; Armero Y; Amat E; Soy D; Moreno A; del Río A; Almela M; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM;
Antimicrob Agents Chemother; 2008 Jul; 52(7):2538-43. PubMed ID: 18426900
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.
Hegde SS; Okusanya OO; Skinner R; Shaw JP; Obedencio G; Ambrose PG; Blais J; Bhavnani SM
Antimicrob Agents Chemother; 2012 Mar; 56(3):1578-83. PubMed ID: 22155835
[TBL] [Abstract][Full Text] [Related]
17. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models.
LaPlante KL; Leonard SN; Andes DR; Craig WA; Rybak MJ
Antimicrob Agents Chemother; 2008 Jun; 52(6):2156-62. PubMed ID: 18411321
[TBL] [Abstract][Full Text] [Related]
18. The issue beyond resistance: Methicillin-resistant Staphylococcus epidermidis biofilm formation is induced by subinhibitory concentrations of cloxacillin, cefazolin, and clindamycin.
Mirzaei R; Yousefimashouf R; Arabestani MR; Sedighi I; Alikhani MY
PLoS One; 2022; 17(11):e0277287. PubMed ID: 36350834
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Steed ME; Vidaillac C; Rybak MJ
Antimicrob Agents Chemother; 2012 Feb; 56(2):955-9. PubMed ID: 22123693
[TBL] [Abstract][Full Text] [Related]
20. Activity of Exebacase (CF-301) against Biofilms Formed by Staphylococcus epidermidis Strains Isolated from Prosthetic Joint Infections.
Souche A; Kolenda C; Teoli J; Schuch R; Ferry T; Laurent F; Josse J
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0058822. PubMed ID: 35861539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
